JPMorgan Chase & Co. lowered its stake in shares of Integer Holdings Co. (NYSE:ITGR – Get Rating) by 5.9% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 236,567 shares of the medical equipment provider's stock after selling 14,765 shares during the quarter. JPMorgan Chase & Co.'s holdings in Integer were worth $19,060,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Advisor Group Holdings Inc. raised its position in Integer by 25.0% in the fourth quarter. Advisor Group Holdings Inc. now owns 5,155 shares of the medical equipment provider's stock valued at $442,000 after purchasing an additional 1,031 shares during the period. American Century Companies Inc. raised its position in Integer by 24.0% in the fourth quarter. American Century Companies Inc. now owns 4,610 shares of the medical equipment provider's stock valued at $395,000 after purchasing an additional 893 shares during the period. abrdn plc raised its position in Integer by 10.3% in the fourth quarter. abrdn plc now owns 790,246 shares of the medical equipment provider's stock valued at $67,637,000 after purchasing an additional 73,531 shares during the period. ProShare Advisors LLC raised its position in Integer by 61.6% in the fourth quarter. ProShare Advisors LLC now owns 8,177 shares of the medical equipment provider's stock valued at $701,000 after purchasing an additional 3,118 shares during the period. Finally, First Trust Advisors LP raised its position in Integer by 2.8% in the fourth quarter. First Trust Advisors LP now owns 16,664 shares of the medical equipment provider's stock valued at $1,426,000 after purchasing an additional 460 shares during the period. Institutional investors and hedge funds own 99.26% of the company's stock.
Get
Integer alerts:
Insiders Place Their Bets
In other Integer news, insider Carter Houghton sold 2,708 shares of the company's stock in a transaction dated Friday, August 12th. The stock was sold at an average price of $74.13, for a total transaction of $200,744.04. Following the sale, the insider now owns 3,262 shares in the company, valued at approximately $241,812.06. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.01% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
ITGR has been the topic of a number of research analyst reports. TheStreet downgraded Integer from a "b-" rating to a "c+" rating in a research report on Friday, May 13th. KeyCorp cut their price objective on Integer from $109.00 to $97.00 and set an "overweight" rating on the stock in a report on Friday, July 29th.
Integer Price Performance
ITGR stock opened at $60.67 on Tuesday. The company has a current ratio of 2.70, a quick ratio of 1.71 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $2.01 billion, a PE ratio of 26.04 and a beta of 1.23. Integer Holdings Co. has a 12-month low of $60.08 and a 12-month high of $99.92. The business's fifty day moving average price is $69.83 and its 200 day moving average price is $75.43.
Integer (NYSE:ITGR – Get Rating) last issued its quarterly earnings results on Thursday, July 28th. The medical equipment provider reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.18 by ($0.14). Integer had a return on equity of 9.50% and a net margin of 6.10%. The company had revenue of $350.10 million for the quarter, compared to analysts' expectations of $343.57 million. During the same quarter last year, the company earned $1.07 EPS. Integer's revenue for the quarter was up 12.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Integer Holdings Co. will post 4.3 EPS for the current year.
Integer Profile
(Get Rating)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.
Featured Articles
- Get a free copy of the StockNews.com research report on Integer (ITGR)
- MarketBeat Podcast: Stock Market, Bad News is Good News
- Forget Bitcoin, Block's Ecosystems are the Real Growth Drivers
- What Does an Inverted Yield Curve Mean For You?
- SPY vs. QQQ: Which ETF Wins in 2022?
- Could Snap Stock Rebound As Management Restructures?
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR – Get Rating).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
